LOS ANGELES, CA / ACCESSWIRE / July 10, 2017 / StockNewsNow.com, The Official MicroCap News Source™ has published online its SNNLive video interview with William Febbo, CEO of OptimizeRx (OTCQB: OPRX), recorded at the LD Micro Invitational Conference in Bel Air, California on June 7, 2017.

OptimizeRx provides marketing services to the pharmaceutical industry and is one of the largest aggregators of pharmaceutical company-sponsored services delivered through electronic health record (EHR) platforms. The OptimizeRx platform is integrated with more 370 EHRs reaching more than 500,000 health care providers, according to the company's website (see here: www.optimizerx.com).

Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:

OptimizeRx Corp. – Digital Health Company Supplying Marketing Services to the Pharmaceutical Industry


Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer

About OptimizeRx Corp.

Based in Rochester, Michigan, OptimizeRx Corporation (OTCQB: OPRX) is a health technology software company that is changing the point of care experience through technology to improve clinical decisions and outcomes. OptimizeRx's unique consumer and physician platforms help patients better afford and comply with their medicines and healthcare products while offering pharmaceutical and healthcare companies effective ways to expand awareness, access, and adherence to their medications.

OptimizeRx core product replaces drug samples with electronic trial vouchers and copay coupon savings that are electronically added to an e-Prescription and sent electronically to the pharmacy and is integrated within leading electronic health record (EHR) platforms in the country, including Allscripts, DrFirst, NewCrop, Quest Diagnostics, Practice Fusion and other EHRs to reach over 500,000 healthcare providers. In turn, OptimizeRx promotes patient savings and support from the world's largest pharmaceutical companies, including Pfizer, Merck, Lilly, Novartis, AstraZeneca and many others.

For more information and company description, please visit: www.OptimizeRx.com

About StockNewsNow.com

StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.

Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for - all here on StockNewsNow.com.


Important Cautions Regarding Forward-Looking Statements

This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.

Investor Relations Contact for OptimizeRx:

Ron Both or Grant Stude, CMA

Tel (949) 432-7557


SOURCE: Stock News Now